Oxford Wealth Group’s Amgen AMGN Stock Holding History

Oxford Wealth Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$333K	Sell	946 -18	-2%	-$6.42K	0.18%	75
2025 Q4	$316K	Buy	+964	New	+$306K	0.15%	77
2024 Q4	$254K	Hold	973	–	–	0.16%	54
2024 Q3	$314K	Sell	973 -36	-4%	-$11.8K	0.26%	51
2024 Q2	$315K	Sell	1,009 -42	-4%	-$12.3K	0.22%	52
2024 Q1	$299K	Buy	+1,051	New	+$308K	0.27%	46

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Oxford Wealth Group's AMGN Position: Q1 2026 in Review

Oxford Wealth Group reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $6.42K and leaving 946 shares worth $333K. The position accounts for 0.18% of the portfolio, ranked #75.

Oxford Wealth Group first reported a position in AMGN in Q1 2024 and has held it in 6 quarters since. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Oxford Wealth Group held 946 shares of Amgen worth $333K as of Q1 2026.
Oxford Wealth Group sold 18 Amgen shares in Q1 2026, an estimated $6.42K.
Amgen made up 0.18% of Oxford Wealth Group's portfolio in Q1 2026, its #75 holding.
Oxford Wealth Group first reported a position in Amgen in Q1 2024 and has held it in 6 quarters since.
3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Oxford Wealth Group's 13F filing for Q1 2026, filed 11 May 2026.